Arctoris Logo

Arctoris Risk Report

Explore Arctoris across six non‑financial risk dimensions:ESG, Workforce, News & Media, Cybersecurity, Legal & Regulatory, Operational. Unlock the full report, original sources and timelines, and enable continuous monitoring.

Generated on
July 17, 2025
Warnings
1
After signup you can monitor companies and receive early‑warning alerts.

Summary

📜 Innovation & R&D

Arctoris has demonstrated a consistent focus on innovation and collaborative research to advance drug discovery. They have formed strategic partnerships with other tech and pharma companies to enhance their research capabilities. Notably, these collaborations often aim to leverage cutting-edge technologies like AI and robotics to accelerate drug discovery processes.

  • On 🗓 September 13, 2021, Arctoris partnered with IBM Research to use AI and cloud technology for closed-loop drug discovery, improving efficiency in their research operations.
  • Arctoris celebrated its 5th anniversary by launching an expanded robotic platform, Ulysses, on 🗓 February 24, 2021. This development underscores their commitment to enhancing research capabilities through automation.
  • Their partnership with Insilico Medicine announced on 🗓 July 9, 2020, focused on discovering new COVID-19 drugs, demonstrating agility in addressing urgent public health challenges.

👥 Labor & Workforce

Arctoris has been strategically expanding its workforce, as highlighted by recent efforts to build a robust executive team. This growth reflects the company's continued expansion and its commitment to sustaining operational excellence through a strong leadership foundation.

  • Following significant growth, Arctoris announced the expansion of its executive team on 🗓 August 26, 2024, indicative of its need for enhanced leadership to manage its increasing operations.

🏗️ Operational & Business Continuity

There have been key operational advancements by Arctoris, which ensure its business continuity and respond to evolving market demands. The acquisition of strategic assets and partnerships with other companies have been pivotal to maintaining operational resilience.

  • Arctoris acquired Eli Lilly's Life Sciences Studio Lab, moving an automation platform from San Diego to Oxford, on 🗓 September 13, 2024. This move is strategic in bolstering their operational capability in critical locations.

🏅 Awards & Recognition

Arctoris has been recognized within the industry as a leading entity in the field of cloud robotics, furthering its reputation as a forward-thinking and innovative company.

  • Arctoris was identified as one of the top 10 cloud robotics start-ups on 🗓 July 22, 2021, underscoring its position as a pioneering force in integrating robotics with research activities.

Profile

Founded Year
2016
Social Media
Specialties
AI, Biotech, IND, PROTACs, antibodies, automation, biochemistry, cell biology, drug development, drug discovery, fundamental research, hit ID, hit-to-lead, lead optimization, machine learning, molecular biology, novel therapeutics, robotics, small molecule, target validation

News & Media

Real‑time aggregation of trusted sources tracking company‑related events with sentiment and topic tags for rapid risk triage.

Entity List

Continuous third‑party screening across global sanctions, enforcement, and watchlist sources with unified entity resolution and real‑time alerts.

NameIssuerStatus
ACF List of War EnablersAnti-Corruption Foundation
African Development Bank Debarred EntitiesAfrican Development Bank Group
Argentina Members of ParliamentHonorable Cámara de Diputados de la Nación Argentina
Argentina RePET SanctionsMinisterio de Justicia
Armenia Public Officials and AssociatesHetq Online
Asian Development Bank SanctionsAsian Development Bank
Australian Sanctions Consolidated ListDepartment of Foreign Affairs and Trade
Democratic People's Republic Of Korea (North Korea) Sanctions RegimeDepartment of Foreign Affairs and Trade
Former Federal Republic Of Yugoslavia Sanctions RegimeDepartment of Foreign Affairs and Trade
Iran Sanctions RegimeDepartment of Foreign Affairs and Trade

Sign up to unlock Arctoris’s sanctions, enforcement, and watchlist risk profile.

View Full Report

ESG

Verification of declared ESG commitments and certifications with evidence links, score signals, and status updates across E, S, and G.

NameStatus
Sustainable Finance Disclosure Regulation
Global Reporting Initiative Standards
EU Taxonomy Regulation
EU Corporate Sustainability Reporting Directive
California Transparency in Supply Chains Act
EU Non-Financial Reporting Directive
ISO 14001
Sustainability Accounting Standards Board Standards
Task Force on Climate-related Financial Disclosures
UN Guiding Principles on Business and Human Rights

Sign up to unlock Arctoris’s ESG commitments, certifications, and controversy signals.

View Full Report

Cybersecurity

Verification of adherence to recognized security standards, mapping control coverage and gaps affecting third‑party and supply‑chain risk.

CertificationStatus
General Data Protection Regulation
Digital Operational Resilience Act
Cybersecurity Maturity Model Certification
NIST Cybersecurity Framework
NIST 800-53 Revision 5
California Consumer Privacy Act
ISO/IEC 27001
Health Insurance Portability and Accountability Act
Payment Card Industry Data Security Standard
Federal Information Security Modernization Act

Sign up to unlock Arctoris’s security standards, control gaps, and exposure risks.

View Full Report

Get Arctoris's full Non-Financial Risk Report

By signing up, you agree to our Terms and Privacy Policy.